Literature DB >> 15287725

Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.

Lev Becker1, P Michael Cook, Marlys L Koschinsky.   

Abstract

We have previously demonstrated that, in the presence of the lysine analogue epsilon-aminocaproic acid, apolipoprotein(a) [apo(a)] undergoes a conformational change from a closed to an open structure that is characterized by a change in tryptophan fluorescence, an increase in the radius of gyration, an alteration of domain stability, and an enhancement in the efficiency of covalent lipoprotein(a) [Lp(a)] formation. In the present study, to identify sequences within apo(a) that maintain its closed conformation, we used epsilon-aminocaproic acid to probe the conformational status of a variety of recombinant apo(a) isoforms using analytical ultracentrifugation, differential scanning calorimetry, intrinsic fluorescence, and in vitro covalent Lp(a) formation assays. We observed that the closed conformation of apo(a) is maintained by intramolecular interaction(s) between sequences within the amino- and carboxyl-terminal halves of the molecule. Using site-directed mutagenesis, we have identified the strong lysine-binding site present within apo(a) kringle IV type 10 as an important site within the C-terminal half of the molecule, which is involved in maintaining the closed conformation of apo(a). Apo(a) exhibits marked isoform size heterogeneity because of the presence of varying numbers of copies of the kringle IV type-2 domain located within the amino-terminal half of the molecule. Using recombinant apo(a) species containing either 1, 3, or 8 copies of kringle IV type 2, we observed that, while apo(a) isoform size does not alter the affinity of apo(a) for low-density lipoprotein, it affects the conformational status of the protein and therefore influences the efficiency of covalent Lp(a) assembly. The inverse relationship between apo(a) isoform size and the efficiency of covalent Lp(a) formation that we report in vitro may contribute to the inverse relationship between apo(a) isoform size and plasma Lp(a) concentrations that has been observed in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287725     DOI: 10.1021/bi049536d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a).

Authors:  Justin R Clark; Matthew Gemin; Amer Youssef; Santica M Marcovina; Annik Prat; Nabil G Seidah; Robert A Hegele; Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2022-04-22       Impact factor: 6.676

2.  Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).

Authors:  Rocco Romagnuolo; Santica M Marcovina; Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2014-01-29       Impact factor: 5.922

3.  Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway.

Authors:  Taewoo Cho; Yoojin Jung; Marlys L Koschinsky
Journal:  J Biol Chem       Date:  2008-09-05       Impact factor: 5.157

4.  Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.

Authors:  Rocco Romagnuolo; Corey A Scipione; Santica M Marcovina; Matthew Gemin; Nabil G Seidah; Michael B Boffa; Marlys L Koschinsky
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

5.  Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.

Authors:  Catarina Oliveira; Carole Fournier; Véronique Descamps; Virginie Morel; Corey A Scipione; Rocco Romagnuolo; Marlys L Koschinsky; Agnès Boullier; Paulo Marcelo; Jean-Marc Domon; Etienne Brochot; Gilles Duverlie; Catherine Francois; Sandrine Castelain; Francois Helle
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

6.  Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.

Authors:  Lei Liu; Michael B Boffa; Marlys L Koschinsky
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.